Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

July 3, 2024

Arvinas Inc. names new CFO

New Haven biotech company Arvinas Inc. has named Andrew Saik its new chief financial officer and treasurer.

Saik has more than 20 years of biopharma finance experience, most recently serving as chief financial officer at Intercept Pharmaceuticals Inc. While at Intercept, he led the effort to recapitalize the balance sheet by selling the international division for $450 million and then repurchasing $390 million in convertible debt with a combination of cash and stock. 

Prior to Intercept Pharmaceuticals, Saik was CFO of Vyne Therapeutics Inc. He replaces Sean Cassidy, who left Arvinas in February.

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF